Whole genome
Full sequence, not a targeted panel. Variants scored against clinical outcomes.
The product
A computational model of one patient's biology, built by OASIS AI and queryable by their clinician.
Not a report you read once. A model you interrogate, and one that updates as the patient responds.
Architecture
Each stream is analyzed against the others, not in isolation. That is the whole point of integrated science.
Full sequence, not a targeted panel. Variants scored against clinical outcomes.
Gut composition and metabolic output, read as an active driver of disease.
Inflammatory, metabolic, hormonal, and immune panels.
Diagnoses, prior treatment response, and medication history.
Nutrition, sleep, activity, and stress inputs the patient can change.
Exposure and geographic risk factors layered onto the biology.
The core
OASIS: Omics Analytics System for Integrated Science
Running on OASIS AI Cloud. HIPAA compliant, SOC 2 Type II certified.
Quantified risk across cardiometabolic, autoimmune, oncologic, and neuropsychiatric domains.
The specific inflammatory or metabolic pathways driving this patient's presentation.
Candidate interventions ranked by the patient's own molecular signal.
Which markers to re-check, when, and what a response looks like.
Clinical journey
Clinician orders the Shifa panel.
Standard phlebotomy, stool sample, structured intake.
OASIS AI builds the Molecular Twin™. 1–2 weeks.
Report to the EHR; serial markers drive adjustment.
Questions

Next step